Dedicated to embryonic competence and research

Since 2014, the Foundation for Embryonic Competence (FEC) has awarded nearly $2 million to support research in the field of embryonic competence. We are proud to support numerous research studies through our supported research and fellowship grant programs. All funding is made possible through proceeds earned through our NexCCS and IdentifySGD diagnostic tests.

Research into factors relating to embryonic reproductive potential has been difficult to fund. Traditional sources, such as the National Institutes of Health (NIH), are prohibited from supporting much of the work needed in this critical area.

All funding is made possible through proceeds earned through our NexCCS and IdentifySGD diagnostic tests.

Investigator-initiated grants from the pharmaceutical industry and biotechnology companies have also diminished in recent years. The lack of support likely means that some investigators with great ideas, particularly those who are young and without established funding histories, will be unable to pursue meaningful research, thus having the undesired effect of slowing progress in our field.

Fellowship Grant Program

The FEC recently established a grant program to provide up to $70,000 to support individual first- and second-year reproductive endocrinology fellows investigating factors influencing embryonic reproductive competence. This includes investigating related techniques and factors that may actually improve the opportunity for embryos to implant and progress to delivery.

Supported Research

We currently support multiple research studies that are actively recruiting:
Solaire is a clinical trial that aims to assess the impact of NexCCS on patients with low ovarian reserve in order to improve in vitro fertilization (IVF) success and decrease the time to successful pregnancy.

The Natural Cycle Study monitors the development of naturally selected follicles without the use of stimulating drugs. The goal is to examine endometrial changes and assess aneuploidy rates in embryos within the natural IVF cycle.

Summit aims to determine the impact of two FDA-approved blastocyst culture media on pregnancy outcomes.

Nexgen is a clinical trial that aims to assess the effectiveness of next generation sequencing (NGS) based preimplantation genetic diagnosis (PGD) to aid in the selection of embryos for transfer during clinical IVF cycles.

The objective of the EnMotion clinical research study is to evaluate the impact of a dynamic culture system, or a culture system where embryos can move as they do naturally, on the reproductive potential of embryos created during IVF.

The purpose of this study is to determine if sperm DNA fragmentation is associated with IVF outcomes when euploid embryos are transferred.

Questions about open studies may be directed to